SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.68 |
Enterprise Value ($M) | 12.07 |
Book Value ($M) | 3.72 |
Book Value / Share | 0.04 |
Price / Book | 2.07 |
NCAV ($M) | -7.39 |
NCAV / Share | -0.09 |
Price / NCAV | -1.04 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.26 |
Return on Assets (ROA) | -1.09 |
Return on Equity (ROE) | -2.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.55 |
Current Ratio | 0.74 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 11.69 |
Assets | 22.80 |
Liabilities | 19.08 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.95 | 96.44 | |
13D/A | Ianchulev Tsontcho | 3.20 | -7.93 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1 | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,556,488 | 25,056,836 | 34.15 | |
5,174,153 | 22,969,372 | 22.53 | |
6,723,676 | 19,496,021 | 34.49 | |
5,212,884 | 13,245,863 | 39.35 | |
(click for more detail) |
Similar Companies | |
---|---|
ERNA – Eterna Therapeutics Inc. | ESLA – Estrella Immunopharma, Inc. |
EVOK – Evoke Pharma, Inc. | FBIO – Fortress Biotech, Inc. |
FBRX – Forte Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io